Biogen Idec, Inc. (Massachusetts) (BIIB) Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
5/21/2013
More...
|
Baxter International, Inc. (BAX) Receives Marketing Authorization for HyQvia in European Union
5/21/2013
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Release: Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease Who Had Failed or Could Not Tolerate Oral Iron Therapy
5/21/2013
More...
|
Medivir AB (MVIRb.F) Release: Primary Efficacy and Safety Findings From Phase III Study of Simeprevir in Treatment-Experienced Patients Demonstrate Sustained Virologic Response
5/21/2013
More...
|
Vectura Group plc (VEC.L) Release: New Data Presented at the American Thoracic Society Meeting Highlights Strength of Once-Daily COPD Portfolio in Improving Lung Function, Shortness of Breath and Reducing Rate of Exacerbations
5/21/2013
More...
|
Boehringer Ingelheim Corporation Release: Phase III Results: Tiotropium* Respimat® Effective in Symptomatic Asthma Patients Despite at Least ICS†/LABA‡ Independent of Their Age, Allergic Status, Smoking Status and Bronchodilator Response
5/21/2013
More...
|
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen Research & Development's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
5/21/2013
More...
|
AstraZeneca PLC (AZN) Release: Results From Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
5/21/2013
More...
|
AcelRx Pharmaceuticals (ACRX) Drug Device Meets Main Goal of Late-Stage Study
5/21/2013
More...
|
Verona Pharma Release: Further Clinical Data Highlighting the Significant Bronchodilator Activity of Novel Dual PDE3/4 Inhibitor RPL554 Presented at American Thoracic Society International Conference
5/21/2013
More...
|
MacroGenics, Inc. Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients With Metastatic Breast Cancer
5/21/2013
More...
|
Ceregene, Inc. Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study
5/21/2013
More...
|
Oncopeptides AB Secures Venture Funding for Phase II Trial of Melflufen in Multiple Myeloma Patients
5/21/2013
More...
|
TRANSGENE (TRGNY) Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
5/21/2013
More...
|
Jennerex, Inc. Announces Completion of Enrollment in Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
5/21/2013
More...
|
Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial
5/21/2013
More...
|
ChemoCentryx, Inc. (CCXI) Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor
5/21/2013
More...
|
Medivir AB (MVIRb.F) Release: Positive Results From a Phase Ia Study With MIV-711 for the Treatment of Skeletal Disorders
5/21/2013
More...
|
NeuroSigma, Inc. Release: Positive Results Reported for Phase I Clinical Trial at University of California, Los Angeles (UCLA) for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
5/21/2013
More...
|
CytRx Corporation (CYTR) Announces Initial Results From Pharmacokinetics Clinical Trial With Aldoxorubicin in Solid Tumors
5/21/2013
More...
|
Addex Therapeutics (ADXN.SW) Validates Potential Efficacy Biomarker for Phase 1 Trial of Its GABA-B Positive Allosteric Modulator, ADX71441
5/21/2013
More...
|
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR)
5/21/2013
More...
|
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1
5/21/2013
More...
|
Integrated DNA Technologies Release: miRNA Regulated Networks Identified in Cystic Fibrosis
5/21/2013
More...
|
OvaScience Publishes Article Highlighting the Role of Mitochondria in Improving Fertility Outcomes
5/21/2013
More...
|
Echo Therapeutics (ECTE) Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System
5/21/2013
More...
|
AlphaMed Release: Stem Cells From Fat Outperform Those From Bone Marrow in Fighting Disease
5/21/2013
More...
|
Acorda Therapeutics (ACOR) Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple Sclerosis
5/21/2013
More...
|
Rainbow BioSciences, LLC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
5/21/2013
More...
|
Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine
5/21/2013
More...
|
More Details About Hisun-Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK)-Simcere Pharmaceutical Group JVs
5/21/2013
More...
|
EMD Millipore and PharmaCell BV to Develop Optimized Large-Scale Expansion and Harvesting of HepaRG® Cells Grown From Bioreactors
5/21/2013
More...
|
Rosetta Genomics Ltd. (ROSG) Announces Credentialing Agreement With Prime Health Services for miRview mets2
5/21/2013
More...
|
Liquidia Technologies Inc. Announces Extension of Collaboration With PATH to Develop Next Generation Pneumococcal Vaccine
5/21/2013
More...
|
KineMed, Inc. Announces an Agreement With MedImmune (AZN) to Study Protein Dynamics Related to Neurodegenerative Diseases
5/21/2013
More...
|
Cancer Genetics, Inc. Signs Agreement With MultiPlan
5/21/2013
More...
|
AmorChem l.p. and Univalor, L.P. Announce the Success of the First Phase of Their Collaboration With Dr. Nabil Seidah
5/21/2013
More...
|
Clinverse Announces Strategic Alliance With Aggregate Spend Solutions, LLC
5/21/2013
More...
|
Duchesnay USA Release: Diclegis® Now Available Nationwide to Treat Pregnant Women With Nausea and Vomiting of Pregnancy (NVP)
5/21/2013
More...
|
Avion Pharmaceuticals, Launches Prenate Chewable™, the Newest Addition to the Prenate® Prenatal Vitamin Family
5/21/2013
More...
|
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH
5/21/2013
More...
|
TRANSGENE (TRGNY) Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
5/21/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Announces Proposed Public Offering of 6,000,000 Shares of Its Common Stock
5/21/2013
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock
5/21/2013
More...
|
H. Lundbeck A/S (LUN.CO) – Admittance to Trading and Official Listing of New Shares Due to Exercise of Warrants
5/21/2013
More...
|
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - March 2013
5/21/2013
More...
|
Vectura Group plc (VEC.L) Preliminary Results
5/21/2013
More...
|
New Release of Accelrys Inc. (ACCL) Electronic Lab Notebook Transforms Laboratory Operations
5/21/2013
More...
|
TNI BioTech Stock to Begin Trading on the OTCQB Marketplace
5/21/2013
More...
|
RNL Bio and Human Biostar to Offer Direct-to-Consumer Adult Stem Cell Banking in the United States
5/21/2013
More...
|
Royalty Pharma Increases Offer for Elan Corporation PLC (ELN) to $12.50 Per Share in All Cash
5/21/2013
More...
|
Landauer (LDR) Declares Regular Cash Dividend
5/21/2013
More...
|
From Novel Research to Innovative Medicines: GlaxoSmithKline (GSK) Launches Discovery Fast Track Competition for Academic Researchers
5/21/2013
More...
|
Federal Appellate Court Rules in Favor of Mylan Inc. (MYL) in Patent Infringement Litigation Relating to Sunovion's Brovana® Product
5/21/2013
More...
|
ClinTec GmbH Expands Further in MENA Region With Proposed Opening of Istanbul Office
5/21/2013
More...
|
TEMIS Unveils Luxid® for Microsoft SharePoint 2013
5/21/2013
More...
|
Agilent Technologies, Inc. (Santa Clara, California) (A) Introduces OpenLAB Data Store for Mass Spectrometry
5/21/2013
More...
|
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – March 2013
5/21/2013
More...
|
Patheon Inc. (PTI.TO) Announces Date of Fiscal 2013 Second Quarter Financial Results
5/21/2013
More...
|
Pressure BioSciences, Inc. (BBII) Reports Strong First Quarter 2013 Financial Results
5/21/2013
More...
|
Uroplasty, Inc. (UPI) to Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results on May 30, 2013
5/21/2013
More...
|
inVentiv Health (VTIV) Names Sydney Rubin as Chief Communications Officer
5/21/2013
More...
|
Diabetes Research Institute President and CEO Robert A. Pearlman Stepping Down After 20 Years
5/21/2013
More...
|
Anaheim Clinical Trials (ACT) Hires New Japanese Recruitment Head to Speed Enrollment and Study-Startup as Requests for Japanese Bridging Studies Increase
5/21/2013
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB) Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry Veterans
5/21/2013
More...
|
Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine
5/21/2013
More...
|
Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for Diversity Alliance for Science
5/21/2013
More...
|
SCM Pharma Limited Appoints New Director
5/21/2013
More...
|
Association of Clinical Research Organizations (ACRO) Joins Coalition of Small Business Innovators
5/21/2013
More...
|
Vectura Group plc (VEC.L) Board Change
5/21/2013
More...
|
Upsher-Smith Laboratories Introduces Newly Redesigned Corporate Website
5/21/2013
More...
|
Biotechnology Industry Organization (BIO) Welcomes EPA Proposed Rule on New RFS2 Pathways
5/21/2013
More...
|
Biotechnology Industry Organization (BIO) Joins Coalition of Small Business Innovators
5/21/2013
More...
|
Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
5/21/2013
More...
|
Quintiles, Inc. (QTRN) Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
5/21/2013
More...
|
SBS Group Selected to Bob Scott's Insights Top 100 VARs for Third Consecutive Year
5/21/2013
More...
|
Patient Compliance: an Interview With Innovus Pharma CEO Damaj Outlines Worldwide Growth Plans for the Company
5/21/2013
More...
|
Gentiva Health Services (GTIV) to Present at Upcoming Investor Conferences
5/21/2013
More...
|
Valeant Pharmaceuticals International (VRX) to Present at 34th Annual Goldman, Sachs & Co. Global Healthcare Conference
5/21/2013
More...
|
Complix NV to Present at Upcoming BioEquity Europe 2013
5/21/2013
More...
|
Boehringer Ingelheim Corporation Presents Phase 3 Sub-Analyses for Tiotropium Across a Range of Symptomatic Asthma Patients at American Thoracic Society 2013
5/21/2013
More...
|
Verastem, Inc. (VSTM) to Present at Upcoming Conferences
5/21/2013
More...
|
Medidata Solutions, Inc. to Present at the 14th Annual B. Riley & Co. Investor Conference
5/21/2013
More...
|
Safeguard Scientifics (SFE) Annual Meeting of Shareholders to be Held on Thursday, May 23 at 8:00 A.M. EDT
5/21/2013
More...
|
AstraZeneca PLC (AZN) Release: Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
5/21/2013
More...
|
Elekta Nomination Committee’s Proposals for the 2013 Annual General Meeting
5/21/2013
More...
|
Prima Biomed (PRR.AX) to Present at the Second Annual Marcum LLP Microcap Conference
5/21/2013
More...
|
Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the U.S.
5/21/2013
More...
|
Two in Three Cancer Patients Are Non-Adherent With Their Medications, According to Kantar Health Research
5/21/2013
More...
|
Proteostasis Therapeutics, Inc. Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference
5/21/2013
More...
|
Biotechnology Industry Organization (BIO) Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy
5/21/2013
More...
|
Cordis Corporation (JNJ) Showcases Cardiovascular Innovations at EuroPCR 2013
5/21/2013
More...
|
Synthetic Biologics, Inc. (SYN) to Present at the 2nd Annual Marcum LLP MicroCap Conference
5/21/2013
More...
|
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
5/21/2013
More...
|
OncoSec Medical Inc. to Present at the Second Annual Marcum LLP MicroCap Conference
5/21/2013
More...
|
Stellar Biotechnologies, Inc. to Present at the Second Annual Marcum LLP Microcap Conference
5/21/2013
More...
|
Genomic Health, Inc. Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
5/21/2013
More...
|
Cancer Genetics, Inc. to Attend American Society of Clinical Oncology Annual Meeting
5/21/2013
More...
|
Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Late-Breaking Abstract Session During Digestive Disease Week 2013
5/21/2013
More...
|